Deep Medicine to stand the test of time
We always overestimate the change that will occur in the next two years and underestimate the change that will occur in the next ten. Don't let yourself be lulled into inaction, Bill Gates
Since the massive public shows of artificial intelligence capabilities pioneered by IBMs DeepBlue outperforming a human chess player and Watson beating human players in Jeopardy, the word artificial intelligence started making headlines. Many of these capabilities failed to produce tangible practical results, giving the AI skeptics the platform to resist the adoption of AI in their organizations. But this situation changed dramatically in 2014 when deep neural networks started outperforming other algorithms and even humans in image recognition and then in other tasks.
While many concepts in deep learning date back to the mid-20th century, it was the 2014 ImageNet competition that demonstrated that the error rates of the deep learning systems fell below human error rates. This was the real revolution and renaissance in AI. Suddenly, deep learning systems started solving very practical problems in many areas including image, voice, and text recognition.
The Atari games show by DeepMind and its astonishing acquisition by Google made the word Deep a popular prefix for corporate, service, and product branding. Deep Genomics, Deep Chemistry, Deep Pharma and this brings us to Eric Topols book - Deep Medicine.
Eric Topol chose the best possible name for the book on artificial intelligence in healthcare. It contains the key word from the most disruptive technology and a hint of depth.
But writing a book like Deep Medicine is a gargantuan task. It is important to understand the healthcare industrys main problems and how messy this industry is to appreciate the importance and gravity of the book.
Healthcare is a very broad field with many segments and AI is a very broad term with many underlying technologies and data types. Another problem is that most of the AI scientists nowadays publish their findings on ArXiv, a manuscript repository that is not peer-reviewed. Many of these AI scientists have no experience in drug discovery, or even basic biology or chemistry. This naturally generates many poor-quality papers on toy data sets by the AI scientists. There are also many papers where data sets with good-quality well-annotated data are used by the bioinformaticians venturing into AI that do not demonstrate the true power of deep learning. Most of these papers will never be translated into real-world applications but are often presented as a finished product. Finally, most startups do not publish at all and it is only possible to judge them by examining their press releases, websites, people, deals, and investors. The industry looks like martial arts before MMA. There are boxers, kickers, and grapplers but only very few mixed martial artists who can understand both the AI components and the practical biology, chemistry, or digital medicine components.
Another problem that I see is the clear split in attitude among the pharmaceutical industry experts. Since the 2014 revolution in deep learning, the pharmaceutical industry split into the three camps:
AI skeptics, who doubt everything about AI and present every bad paper as an industry fiasco and point to IBM Watsons early challenges in the healthcare domain as evidence that AI will never work in the medical field. They look for every opportunity to downplay AIs value and potential. These skeptics are typically biostatisticians, bioinformaticians, and computational chemists, who changed their company titles to be more in-line with the trends. Also, this group includes third-tier AI scientists who do not have any other way to make a name for themselves but to appear as, and appeal to the AI skeptics by dissecting and downplaying the potential of the AI-parts of the research papers.
AI optimists, who take an optimistic yet cautious view on the state and the potential of AI. They typically have a balanced view.
AI hypers, who present every advance as a breakthrough and are very vocal about that. Hypers are primarily people associated with technology companies, including technology giants that invest billions of dollars into the underlying technologies and platforms. These hypers demand more funding and more resources for the grandiose projects intended to solve intelligence.
And finally, in this industry, nobody reads the research papers in depth. For example, very often the heads of AI companies and business development executives ask some of the original inventors of critical technologies about what technology they are using, what problems can they solve and how different they are from the others without taking the time to read the published literature. They do not have the time.
You need to be a real pro in many areas of science and technology to be able to structure a book like that. Deep Medicine solves most of the above problems with a very deep dive into both technology and medicine. Dr. Eric Topol is a medical doctor and a scientist with the h-index of 223 with over 250,000 journal citations. He is in the top 10 most-cited scientists in medicine and is in top 100 top-cited scientists of all time.
AI before and after deep learning
Before the revolution in deep learning IBM invested substantial resources in promotion of AI in healthcare and generated enormous publicity striking big deals with major hospitals and pharmaceutical companies. In the book Topol dissects or maybe vivisects is a more apt term the IBM Watson controversy. He writes that, while IBM initially promoted the AI and super computer technology that powered Watson as capable of better-than-human ability to make diagnoses, further studies showed the technology was deeply flawed.
IBM Watsons experience with MD Anderson, one of the countrys leading cancer centers, was a debacle noteworthy of many missteps, Topol writes. One of the most fundamental was the claim that ingesting millions of pages of medical information was the same as being able to make sense, or use, of the information.
Watsons poor introduction caused many people, including technology experts, to doubt the promise of AI to improve not just the medical field, but also other areas.
Provides a very balanced view
The ability to point out the flaws of past AI implementations without necessarily following those criticisms into cynicism and Luddite-ism is the real strength of Topol and his book, specifically. Perched wisely between utopian optimism and dystopian pessimism, Topol takes a middle position that benefits readers by providing them with a thorough, accurate and well-balanced view of the state of AIs role in next generation medical technology.
Deep Medicine will stand the test of time
Nowadays I truly enjoy reading books from the dotcom era dating to 1999 and 2000 when experts tried to provide an accurate account of the status of the new industry which just emerged and try to forecast into the future. The technology was changing so quickly back then that it was difficult to own a laptop for over a year. The Internet revolution happened and things got exponential. I was studying computer science at Queens University and remember that feeling of missing out on the revolution. Starting or joining a dotcom company was so tempting. The books published back then did not stand the test of time. To quote Bill Gates again: Most people overestimate what they can do in one year and underestimate what they can do in ten years.
But it is not the case with Deep Medicine. It provides a very balanced view. Industry insiders will immediately notice that the author started writing the book a few years and some of the companies mentioned in the book made substantial progress from where they started or changed their business models even before the final publication. This shows how quickly the industry is evolving. And that is one of the reasons the book is valuable. Since it was published exactly five years after the deep learning systems first outperformed humans in image recognition and the field exploded, it provides a rare record of the birth of the industry. Most of the startups leading the field today already made their first steps and demonstrated some capabilities. So for everyone planning to start a company in AI for healthcare, the book will provide valuable background on how it all started. One interesting fact about the industry is that over the past two years the number of AI startups entering the industry declined.
One story I am intimately familiar with was Insilicos Cornucopia of Meaningful Leads study, which was submitted in June and accepted in November 2016. To my knowledge, it is the first peer-reviewed paper on the application of Generative Adversarial Networks (GANs) in drug discovery. And this story is covered in Deep Medicine.
Back in 2016 no one in the pharmaceutical industry believed that this technology could be used in drug design and conference presentations, while entertaining, were met with heavy skepticism. But in 2018 the wind started changing, more scientists joined the effort and the validation experiments are slowly converting the skeptics who are willing to take the time to bridge the gap between the novelty of the AI methods and very basic validation into believers.
Another startup by a deep learning pioneer Brendan Frey called Deep Genomics.The name appeared in Deep Medicine more than once. There are many companies claiming to do AI, Deep Genomics does exactly what their name states and more - credible application of deep learning to a variety of biological problems. In September 2019 Deep Genomics announced the nomination of their first therapeutic candidate. This is no simple feat as they also claim to have discovered a rare disease target and went end-to-end in less than two years.
The main problem with deep learning in healthcare is that while the advances in high-performance computing and data management made it possible to train the systems very quickly, the time it takes to test the output is very long any orders of magnitude longer than in other industries dealing with pictures, videos, and text or even in robotics. It takes a very long time, effort and money to validate molecules in cells and animals and requires close collaboration between the domain experts in both AI and biological, chemical, and medical sciences. Failures are very common and painful.
Deep Medicine not only provides a helicopter view of AI for drug discovery and development but goes further into the limitations, regulatory and ethical considerations. It talks about many aspects that go beyond the capabilities of state-of-art AI, such as compassion and empathy. Like Kai-Fu Lees AI Superpowers, Deep Medicine is a must for every bookshelf. It is also available in audio format for busy professionals who like to absorb content while commuting to work.
Read more from the original source:
- Deep01 Closes Fundraising Led by ASUS and Received the First Purchase Order of Their AI-Based Medical Device in Taiwan - PRNewswire - June 24th, 2020
- Vacuum Cupping Market Comprehensive Insights 2020 to 2026: Kangzhu, Hwato, BeiJing GuoYiYan Medical Technology and Medical Instrument CO., LTD - Cole... - June 24th, 2020
- World Market for Medical Sensors to 2027 and the Impact of Covid-19 - GlobeNewswire - June 24th, 2020
- Laidlaw Venture Partners Continues Strategic Growth with Addition of Jeff Conroy and George Serafin to its Board of Advisors - cnweekly - June 24th, 2020
- How Adopting Factory of the Future Technology Will Help in Medical... - Medical Tech Outlook - June 24th, 2020
- N95 Face Masks Get Pathogen Killing Technology with Addition of New UVC Medical Device - HospiMedica - June 24th, 2020
- This New App Analyzes Your Voice Quality To Diagnose Congestive Heart Failure: Can It Help With Covid-19? - Forbes - June 24th, 2020
- Hospital Furnitures Market | Covid-19 Impact | Demand, Cost Structures, Latest trends, and Forecasts to 2026 | Stryker, Bio Medical Solutions, GPC... - June 24th, 2020
- Securing best distributor is key to commercialisation in the medical field - Small Caps - June 24th, 2020
- MWE receives 1.45m loan to help fight COVID-19 - Med-Tech Innovation - June 24th, 2020
- Immigration Advice Service: the limits of technology in healthcare - Health Europa - June 24th, 2020
- Capillary Blood Collection Devices Market to See Booming Ahead | Global Players are Radiometer Medical ApS, Sarstedt AG & Co, Becton, Dickinson... - June 24th, 2020
- Spine Biologics Market 2020: Challenges, Growth, Types, Applications, Revenue, Insights, Growth Analysis, Competitive Landscape, Forecast- 2025 - Cole... - June 24th, 2020
- Biocept reaches deal to cover out-of-network patients for its liquid biopsy tests - Proactive Investors USA & Canada - June 24th, 2020
- Global Medical Device Software Testing Services Market 2020: Which technology is expected to trend higher? - 3rd Watch News - June 24th, 2020
- Global Medical Imaging Information System Market 2020 Trends, Industry Size, Share, Technology Demand, Growth Drivers and 2026 Forecast Overview -... - June 24th, 2020
- Securing Medical Technology in the Age of COVID-19 - Infosecurity Magazine - June 5th, 2020
- Lumenis MOSES Technology Wins 2020 MedTech Breakthrough Award for Innovation in Surgical Technology - Yahoo Finance - June 5th, 2020
- BioSig Technologies's PURE EP System to be Presented in Heart Rhythm Society 2020 Science Sessions - GlobeNewswire - June 5th, 2020
- The European Medical Device market is projected to grow at a CAGR of 4.7 % between 2020 and 2025. - PRNewswire - June 5th, 2020
- Do OTAs need more regulation? - Washington Technology - June 5th, 2020
- Neuronetics to Present at the William Blair 40th Annual Growth Stock Conference - GlobeNewswire - June 5th, 2020
- 2020 Assessment of the Infectious Diseases Diagnostics Market and Impact of COVID-19 - Growing Number of COVID-19 Tests, Rise in Adoption of AI in... - June 5th, 2020
- Medical Central Gas Station Market Global Insights and Trends to 2026 | Medicoengineering doo, zmc Medical Devices and Medical Gas Systems, INSPITAL... - June 5th, 2020
- Rockford Psychiatric Medical Services provides positive feedback on the use of Nexstim NBT system with theta burst protocol for treatment of... - June 5th, 2020
- Impact of Corona on Medical Ceramics Market : How much will be the total production? - Cole of Duty - June 5th, 2020
- Digital Health Market is Likely to Exhibit Significant CAGR; Rising Popularity of Real-time Solutions will Promote Growth says Fortune Business... - June 5th, 2020
- Lakehead researchers teaming with high-tech firm on medical scheduling software - Northern Ontario Business - June 5th, 2020
- Soft Tissue Market: In-Depth Industry Analysis and Trends Analysis till 2030 - Cole of Duty - June 5th, 2020
- Bioresorbable Scaffold Market 2020 | Know the Latest COVID19 Impact Analysis And Strategies of Key Players: L-3 Communications Holdings, Inc., Hr... - June 5th, 2020
- Top 5 Major End User industries will boost the growth of Smart Pills Technology Market - Cole of Duty - June 5th, 2020
- Medical Tourism Market 2020 Latest Trending Technology, Growing Demand, Application, Types, Services, Regional Analysis and Forecast to 2025 - Cole of... - June 5th, 2020
- Hysteroscopic Endometrial Resection Procedures Market Trends Analysis, Top Manufacturers, Shares, Growth Opportunities, Statistics & Forecast to... - June 5th, 2020
- Amid the COVID-19 crisis and the looming economic recession, the Mannequin-Based Simulation market worldwide will grow by a projected US$3.7 Billion,... - June 5th, 2020
- The Ten Hottest Medical Technologies in 2019 - May 13th, 2020
- Technology engineered at ASU 50 years ago helps battle COVID-19 - ASU Now - May 13th, 2020
- Enhancing recovery: the rise of medical technology in sport - Medical Device Network - May 13th, 2020
- U.S. Officials: Beware Of China And Others Trying To Steal COVID-19 Research - NPR - May 13th, 2020
- How is the pandemic changing investments in HR tech? - Human Resource Executive - May 13th, 2020
- Global Hospital Beds Market (2020 to 2025) - Outlook and Forecast - ResearchAndMarkets.com - Business Wire - May 13th, 2020
- Safe Orthopaedics Announces the Registration of Several Trademarks in Japan - OrthoSpineNews - May 13th, 2020
- Brian Wagner: We need leadership to protect us - Loveland Reporter-Herald - May 13th, 2020
- Scientists are racing to design a face mask that can rip coronavirus apart - Fast Company - May 13th, 2020
- Medical Disinfection and Sterilization Equipment Market Valuation 2020 | Key Trends, Growth Drivers, In Depth Analysis, Solution and Businesss... - May 13th, 2020
- Medical Perfusion Technology Market Growth by Top Companies, Trends by Types and Application, Forecast to 2026 - 3rd Watch News - May 13th, 2020
- The U.S. Army Wants Wearable Tech That Detects the Coronavirus - Popular Mechanics - May 13th, 2020
- Global Medical Rollator Walker Market 2020 Business Outlook with COVID-19 Scenario | Drive DeVilbiss Healthcare, Kaiyang Medical Technology, TOPRO -... - May 13th, 2020
- Gynecological Examination Tables Market Analysis and Demand with Forecast Overview to 2026 - Cole of Duty - May 13th, 2020
- Global Medical Technologies (GMT) at the Forefront of Healthcare Innovations in the Philippines - MB TechNews - May 13th, 2020
- Virtual care in the age of COVID-19 and beyond - Health Europa - May 13th, 2020
- Interdisciplinary research study uses VR Technology to assess interprofessional communication in healthcare education - Nevada Today - May 9th, 2020
- 5 Reasons Why Vapotherm Will Keep Climbing - The Motley Fool - May 9th, 2020
- Biosense Webster Unveils Late-Breaking Results from PRECEPT Study in Patients with Persistent Atrial Fibrillation - BioSpace - May 9th, 2020
- Needle-Free Drug Delivery Devices Market 2020, Booms the Global Industry Growth at Impressive CAGR Over Forecast Period and Dominated by Key... - May 9th, 2020
- COVID-19 pushes healthcare technology transformation in Asia - ASEAN TODAY - May 9th, 2020
- Vancouver theatre being used as space to help create new medical equipment | Venture - Daily Hive - May 9th, 2020
- The Potential Impact of Coronavirus (COVID-19) for Advent of Disruptive Technologies to Support the Growth of the ENT Diagnostic Devices Market During... - May 9th, 2020
- St. Luke's medical technology lab pivots to coronavirus response - The Gazette: Eastern Iowa Breaking News and Headlines - May 8th, 2020
- Tech experts: Widespread adoption of telemedicine, remote monitoring 'here to stay' - FierceHealthcare - May 8th, 2020
- Safe Orthopaedics enters into exclusive negotiations for the acquisition of LCI Medical - OrthoSpineNews - May 8th, 2020
- Wi-Fi at the Nightingale, virtual GP at carehomes, and new technologies related to COVID-19 - MobiHealthNews - May 8th, 2020
- New Data Unveiled at Heart Rhythm 2020 Demonstrate Effectiveness of App-Based Remote Monitoring of Medtronic Cardiac Devices, Significant Reduction in... - May 8th, 2020
- Camber Spine Technologies Announces Nationwide Launch of SPIRA-C Integrated and FORTICO Anterior Cervical Plate - OrthoSpineNews - May 8th, 2020
- The Benefits of Tech Even Those That Don't Cut Costs - The Tech Report - May 8th, 2020
- Pro Medicus: Healthcare IT Developer With Impressive Growth Story - Seeking Alpha - May 8th, 2020
- Michael Schmertzler Joins the Board of ViralClear Pharmaceuticals, a Majority-Owned Subsidiary of BioSig Technologies, Inc. - GlobeNewswire - May 8th, 2020
- Global Disposable Glove Market Insights (2020 to 2025) - Analysis and Forecasts by Manufacturers, Regions, Technology, Application & Product Type... - May 8th, 2020
- Heated Breathing Circuits Market Size, Analytical Overview, Growth Factors, Demand, Trends and Forecast to 2026 | Teleflex Incorporated, Armstrong... - May 8th, 2020
- Latest Research on Hospital Furnitures Market 2020 by Application, Industry Share, End User with top players Stryker, Bio Medical Solutions, GPC... - May 8th, 2020
- Huge Growth Excepted in Cystometry Catheters Market in Upcoming Years Complete Analysis by 2020-2027 Profiling Top Key Players Amecath, Andromeda,... - May 8th, 2020
- It is impossible to get out of stock! The production speed of masks is far beyond your imagination! - ADOTAS - May 8th, 2020
- Fiagon partners with Smith+Nephew to distribute its ENT surgical navigation portfolio in the Asia Pacific region - BioSpace - May 6th, 2020
- AdvaMed launches platform to help scale the production and distribution of ventilators - Medical Plastics News - May 6th, 2020
- AdvaMed Announces VentConnect Online Platform to Scale the Production and Distribution of Ventilators - Business Wire - May 6th, 2020
- What is driving the Interventional Fluoroscopy Systems? Market size? Key players are EMD Medical Technologies, GE Healthcare, Lepu Medical Technology,... - May 6th, 2020
- Outlook on the Worldwide Sleep Apnea Therapeutic & Diagnostic Devices Industry to 2024 - Insights & Forecast with Potential Impact of COVID-19... - May 6th, 2020
- Orthopedic Surgery Instrument Market 2020 Latest Innovations, Trends, Growth Factors and Opportunities by 2026 | Orthofix, Wright Medical Technology,... - May 6th, 2020
- Transcutaneous Bilirubinometer Market 2020 Economic Impact and Future Prospects | Aegis Medical Innovations, Delta Medical International, Drgerwerk... - May 6th, 2020
- U.S. Arms Makers and Medical Device Firms Team Up to Make Ventilators - The New York Times - May 6th, 2020
- Biotech and Investment Veteran Dennis Purcell Joins the Board of ViralClear Pharmaceuticals, a majority-owned subsidiary of BioSig Technologies, Inc.... - May 6th, 2020